TREA

79164322 - 3RND

Follow

Information

  • Trademark
  • 79164322
  • Serial Number
    79164322
  • Registration Number
    4943582
  • Filing Date
    March 14, 2015
    9 years ago
  • Registration Date
    April 26, 2016
    8 years ago
  • Transaction Date
    March 17, 2024
    10 months ago
  • Status Date
    May 25, 2023
    a year ago
  • Published for Opposition Date
    February 09, 2016
    8 years ago
  • Location Date
    May 25, 2023
    a year ago
  • Status Code
    707
  • Employee Name
    CLARK, ROBERT C
  • Attorney Docket Number
    ASEDASCI-6-T
    Attorney Name
    Jeffrey A. Smith
    Law Office Assigned Location Code
    L10
  • Owners
Information
Mark Drawing Code
4000
Mark Identification
3RND
Case File Statements
  • GS0091: [ Database management software; software for application and database integration; software for creating searchable databases; computer application software for mobile phones, cellular phones, handheld computers, smart telephones, PC tablets, personal digital assistants, mobile computers, computers, namely, software used for analysis, storage, data retrieval and visualization of compounds and the cellular effect of compounds in drug discovery; bioinformatics software used to assess the cellular effect of compounds in the drug discovery and development process; computer graphics software; software for accessing information directories that may be downloaded from a global computer network; software for data storage automation; data search software, namely, software for creating searchable database of data; digital image processing software; software for data and document capture, transmission, storage and indexing; scanning software ]
  • PM0001: THREE ROUND
  • GS0421: [ Scientific research and development; ] scientific and technological services, namely, novel multi-parametric phenotypic screening in the nature of analytical testing [ services and protein isolation ] for the characterization and simultaneous identification of multiple biological and physiological effects caused by drug candidates on live human cell models in the field of pharmaceutical research, drug discovery and characterization of compound effect [, and scientific research and development relating thereto ] ; Scientific and technological services for scientific analysis, testing and research in the fields of pharmaceutical research, drug discovery and characterization of compound effect [, and protein separation, isolation and characterization ] ; [ scientific research services; ] scientific testing and analysis in the fields of pharmaceutical research, drug discovery and characterization of compound effect [, and protein separation, isolation and characterization ] ; computer-assisted scientific research, testing and analysis services in the fields of pharmaceutical research, drug discovery and characterization of compound effect by using mathematical and statistical algorithms to compare and predict the effect of a target compound to that of an approved drug or known toxin, where a biological fingerprint is created and analyzed by measuring the broad physiological and biological effect of said compounds on live human cells; [ laboratory research and analysis services in the fields of pharmaceutical research, drug discovery and characterization of chemical compounds, and protein separation, isolation and characterization; pharmaceutical research and development; ] Scientific research and scientific and technological services, namely, analytical testing and phenotypic screening services in the fields of pharmaceutical research, drug discovery and characterization of chemical compounds [, and protein separation, isolation and characterization; scientific laboratory services in the fields of pharmaceutical research, drug discovery and characterization of chemical compounds, and protein separation, isolation and characterization; scientific and technological services, namely, analytical testing and phenotypic screening services in the fields of pharmaceutical research, drug discovery and characterization of chemical compounds, and protein separation, isolation and characterization; provision of information about medical and scientific research in the field of pharmaceuticals; preparation of reports on scientific research; provision of scientific information on technological research in the fields of pharmaceutical research, drug discovery and characterization of chemical compounds; ] provision of scientific information about industrial analysis and research services in the fields of pharmaceutical research, drug discovery and characterization of chemical compounds; [ provision of information and data relating to medical research and development and veterinary medical research; consultancy services in the field of pharmaceutical research; consultancy relating to research and development in the field of therapeutics; engineering and ] scientific consultancy services in the fields of pharmaceutical research, drug discovery and characterization of chemical compounds [, and protein separation, isolation and characterization; provision of technical advice in the field of scientific and industrial research; consultancy in the field of scientific and industrial research ]
Case File Event Statements
  • 3/17/2024 - 10 months ago
    36 - PARTIAL INVALIDATION PROCESSED BY THE IB Type: INNP
  • 2/3/2024 - 12 months ago
    35 - PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB Type: INPS
  • 2/2/2024 - a year ago
    34 - INVALIDATION PROCESSED Type: INPC
  • 1/25/2024 - a year ago
    33 - PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED Type: INPR
  • 5/25/2023 - a year ago
    32 - NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED Type: NA71
  • 5/25/2023 - a year ago
    31 - REGISTERED - PARTIAL SEC 71 ACCEPTED Type: 71.P
  • 5/16/2023 - a year ago
    30 - CASE ASSIGNED TO POST REGISTRATION PARALEGAL Type: APRE
  • 10/25/2022 - 2 years ago
    29 - TEAS SECTION 71 RECEIVED Type: ES71
  • 4/26/2021 - 3 years ago
    28 - COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED Type: REM3
  • 8/12/2016 - 8 years ago
    27 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO
  • 7/27/2016 - 8 years ago
    26 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS
  • 7/27/2016 - 8 years ago
    25 - FINAL DISPOSITION PROCESSED Type: FIMP
  • 7/26/2016 - 8 years ago
    24 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR
  • 4/26/2016 - 8 years ago
    23 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 2/9/2016 - 8 years ago
    22 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 2/9/2016 - 8 years ago
    21 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 2/5/2016 - 8 years ago
    20 - NOTIFICATION PROCESSED BY IB Type: GPNX
  • 1/20/2016 - 9 years ago
    19 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS
  • 1/20/2016 - 9 years ago
    18 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Type: OP2R
  • 1/20/2016 - 9 years ago
    17 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 1/4/2016 - 9 years ago
    16 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 12/17/2015 - 9 years ago
    15 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 12/17/2015 - 9 years ago
    14 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 12/17/2015 - 9 years ago
    13 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 12/17/2015 - 9 years ago
    12 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 10/29/2015 - 9 years ago
    11 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 10/29/2015 - 9 years ago
    10 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 7/11/2015 - 9 years ago
    9 - REFUSAL PROCESSED BY IB Type: RFNT
  • 6/22/2015 - 9 years ago
    8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 6/22/2015 - 9 years ago
    7 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 6/19/2015 - 9 years ago
    6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 6/18/2015 - 9 years ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 6/18/2015 - 9 years ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 5/6/2015 - 9 years ago
    3 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 5/2/2015 - 9 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 4/30/2015 - 9 years ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR